In a ruling that could handicap trademark applicants fighting to salvage their brands, the Fourth Circuit concluded that the government can recover legal fees from applicants that look to district courts to challenge adverse rulings by the Patent and Trademark Office.
Can Sullivan & Cromwell's Bob Giuffra succeed where his predecessors failed?
The justices rebuffed claims that a California judge ignored prior Supreme Court rulings when he certified an antitrust class of more than 100 million consumers alleging billions of dollars in damages.
Barclays' lawyers at Sullivan & Cromwell managed to trim but not defeat claims that the bank misled investors about safeguards in its Liquidity Cross dark pool.
The deal comes three years after AIG accused billionaire Steven Udvar-Hazy of pilfering its aircraft leasing unit, and three months after Quinn Emanuel stepped into the case.
Most top white-collar litigators don't spend part of their careers battling the U.S. Mint over missing coins. But most coins aren't anything like the 1933 Double Eagle.
Ted Olson didn't quite live up to his legend on Monday. The question is whether Chevron blew the case.
A financial crisis case that stumbled on South Korean law regained its footing on Wednesday, when a U.S. appeals court revived claims that Citigroup Inc. duped a Korean bank into investing in a complex investment product that went belly-up in the global recession.
The Second Circuit suggests a do-over of the world's most messed-up case. Others mock the idea—but here's how it could be done.
A judge in Manhattan reused to grant either side summary judgment in a lawsuit accusing Greenberg Traurig of helping a former client deceive his adversaries and the court.
Partner Andrew Tauber built on previous defense victories in litigation related to Medtronic's Infuse spinal fusion device, persuading the Tenth Circuit to rule Tuesday that a plaintiff's state law tort claims over Infuse are pre-empted.
DLA Piper, Milberg and others told a state judge on Tuesday that they didn't violate the law by representing Paul Ceglia in his failed ownership lawsuit against Facebook.
A tenacious patent plaintiff overdid it in a Federal Circuit brief trying to overturn a win for JPMorgan and its lawyers at Skadden.
Beth Wilkinson led a trial team that persuaded St. Louis jurors to clear Pfizer in the first trial of hundreds of pending cases linking Zoloft to birth defects.
Siding with a defense team that included appellate heavyweight Tom Goldstein, a Las Vegas judge ruled that law enforcement officials cut constitutional corners in their case against high-roller Paul Phua.
A day before DLA Piper, Milberg and others must appear in court to defend their decisions to take Paul Ceglia's contract case against Facebook, the Second Circuit underscored the implausibility of Ceglia's claims.
It took more than a decade, but Barry Berke finally claimed victory Friday in his battle with the U.S. government over the fate of 10 of the world's rarest coins.
Arnold & Porter's Lisa Blatt quickly pounced on a ruling by a Philadelphia federal judge that echoed her arguments earlier this week in a closely watched Second Circuit appeal related to Actavis' Alzheimer's drug Namenda.
For the author of "Human Rights in a Nutshell," the lessons of Chevron are pretty simple.
Walker's Sixth Circuit win for Ford Motor Co. was a clear victory for employers that could wind up leaving workers better off as well.
Bank of America, represented by Shearman & Sterling, is the third bank to settle of the dozen targeted in antitrust litigation alleging widespread manipulation in the $5 trillion-per-day foreign exchange market.
A federal appeals court moved a step closer on Wednesday toward resolving a critical issue in the never-ending music copyright wars, agreeing to consider whether the owners of pre-1972 sound recordings have performance rights to their songs.
Microsoft and its allies want the appeals court to reconsider a ruling for a group of Xbox purchasers, arguing that the decision gives class action plaintiffs an unfair opportunity to bring cases back from the dead.
In the latest case sparked by the alleged CDO shenanigans of hedge fund Magnetar Capital, the Second Circuit ruled that FGIC can pursue claims over a $1.5 billion CDO gone bad.
Finding the case was tossed prematurely, a federal appeals court on Monday breathed new life into a proposed class action accusing Abbott Laboratories of paying kickbacks to doctors and marketing the anti-seizure drug Depakote for unapproved uses.
Jones Day's Greg Katsas failed to persuade the full Second Circuit that it should reconsider a panel's decision forcing RJR to face racketeering claims by a coalition of EU countries.
Greece's lawyers at Cleary Gottlieb Steen & Hamilton defeated a treaty arbitration brought by a Slovak bank seeking to avoid a steep haircut on $533 million in Greek bonds.
A Minnesota-based company can't thwart a rival’s patent lawsuit even though the alleged infringing technology was installed on ships on the high seas, a judge in Minneapolis ruled.
Arnold & Porter's Lisa Blatt urged the appeals court to quickly lift an injunction requiring Actavis to keep selling an older version of its blockbuster Alzheimer's drug Namenda, saying a delay could put hundreds of millions of dollars at risk.
Arnold & Porter's Lisa Blatt will try to create important new precedent for the pharmaceutical industry—and save Actavtis' plan to extend patent protection for its blockbuster Alzheimer's drug Namenda.
After chipping away for years at claims that Fixodent denture glue can cause neurological damage, P&G's lawyers at Weil, Gotshal & Manges put the last of the cases to rest this week.
After 12 years of litigation, plaintiffs in the Accutane mass tort can no longer claim the upper hand.
After years of failed efforts, Big Tobacco finally won a decision undercutting the famous Engle ruling. The problem? The industry recently settled nearly every case that might have been affected.
Siding with Abbvie Inc. and its lawyers at Latham & Watkins, the Federal Circuit again rejected efforts by the Kennedy Trust for Rheumatology Research to extend a patent license for the blockbuster anti-inflammatory drug Humira.
Facebook's lawsuit against Paul Ceglia's lawyers isn't the only attorney misconduct case heating up these days—and it's not the only one based on allegations that big-firm lawyers looked the other way when a client doctored documents.
Gibson Dunn's Ted Boutrous and Delaware shareholder lawyer Joel Friedlander will square off Wednesday over an unusual proxy proposal challenging Wal-Mart's sales of high capacity guns and other potentially "offensive" products.
Former Schlumberger lawyer Charlotte Rutherford was supposed to help Acacia deploy its patent arsenal against the Texas oil industry. Schlumberger and its lawyers at Latham & Watkins had other ideas.
After last year's $50 billion arbitration win for the former masters of Yukos Oil Company, we know a defunct oil company can strike a gusher. But can its shareholders get their hands on the loot?
Latham & Watkins' Gregory Garre helped convince a federal appeals court to throw out the mega-award on Monday, reversing a government victory in a roller-coaster case against UTC over fighter jet contracts.
Capitol Records and its lawyers at Jenner & Block claimed the company spent more than $12 million in legal fees to win a copyright damages award of just $12 million against MP3tunes.
After a judge questioned the fine print in Viacom's proposed $7.2 million settlement with former interns, lawyers at Davis Wright Tremaine and Virginia & Ambinder insisted the deal is fair.
Stephen Fishbein of Shearman & Sterling and Mark Pomerantz of Paul Weiss won't have to reargue the successful appeals of Todd Newman and Anthony Chiasson at the Second Circuit.
The owner of two rooftop businesses near the Chicago Cubs' stadium tried to halt the erection of a Jumbotron, claiming the sign would block views and devastate his business.
Ellen Pao's discrimination case against Kleiner Perkins riveted Silicon Valley and grabbed headlines nationwide. And so did Hermle's knockout defense win.
In a setback for defense lawyers at Shearman & Sterling, Barclays plc this week joined an elite but unhappy club of major banks that have been unable to shake antitrust claims by a onetime partner at Pillsbury, Cadwalader and other firms.
The U.S. Securities and Exchange Commission on Wednesday fined technology and engineering company KBR Inc. over confidentiality agreements that, the agency claims, could have silenced potential whistleblowers.
After churning through six law firms, seven judges and more than 17 years of litigation, Pall Corp.'s infringement case against 3M is still alive—and now it may finally be headed to trial.
It didn't take long for "Diva of Distressed" Lynn Tilton and her lawyers at Skadden to take the offensive against the Securities and Exchange Commission.
A judge in Delaware tossed claims that Cisco and Juniper willfully infringed several patents that were originally part of a massive IP portfolio acquired by Rockstar Consortium from the Nortel Networks bankruptcy.
In a win for defense teams at Skadden, DLA Piper and Weil Gotshal, a judge in New York tossed copyright and antitrust claims against the NFL, the Associated Press and Getty Images.
We knew Kasowitz Benson warned DLA Piper that Facebook claimant Paul Ceglia appeared to be a fraud. Now, with Ceglia missing and DLA facing fraud accusations of its own, a ruling gives an idea of just how hard Kasowitz tried to discourage DLA from taking Ceglia's case.
Last year lawyers at Skadden brought a constitutional challenge against the SEC for filing an unrelated case against an investment adviser as an administrative action rather than a federal lawsuit. Will the firm go on the offensive for the "Diva of Distressed" as well?
The defunct, fraud-addled Chinese company Puda Coal was disaster for its investors, and remains a major litigation headache for its bankers. Now the investment bank Macquarie Group wants the lawyers to share the blame.
Latham IP litigators scored back-to-back appellate wins for Mallinckrodt Pharmaceuticals and wrangled $1 million in attorney fees for Volvo.
Ford Motor Co. didn't only beat a quarter-billion dollar patent infringement lawsuit this week. The automaker's lawyers at Wilmer Cutler Pickering Hale and Dorr turned the tables on their opponents, persuading a federal jury that Ford's accuser swiped the company's trade secrets.
To paraphrase Mark Twain, reports on the death of a multibillion-dollar class action against Goldman Sachs and JPMorgan were somewhat exaggerated.
Five years into litigation over an alleged price-fixing scheme by the biggest players in the paper and packaging industry, plaintiffs lawyers gained ground on Thursday when a Chicago federal judge allowed the case to move forward as a class action.
It may take years before the law on "biosimilar" drugs is settled. But for now, MoFo's Krevans and Esposito have set the standard.
Kilpatrick Townsend & Stockton lost a bid to escape claims that it helped a client dupe another company into turning over confidential information.
Big banks have failed to convince courts around the country that various government agencies waited too long to sue over Wall Street's role in the 2008 financial crisis. This week, a judge finally adopted the banks' reasoning in a case brought by the Federal Deposit Insurance Corporation.
After lawyers at Reed Smith and other firms buried him in "behemoth pleadings" in a case involving UPS, a judge in Manhattan finally got fed up.
After a lackluster year for securities class action settlements, fee awards in deals involving IndyMac and AIG highlight the uncertainties facing plaintiffs firms in even the biggest cases.
Oil companies have agreed to shell out millions to settle claims that they failed to disclose the impact of hot weather on the price of fuel. But when a judge considers a slew of proposed settlements later this year, at least two groups will be sounding alarm bells.
The justices held that Omnicare can't be held liable under Section 11 of the Securities Act of 1933 just because it offered opinions in a regulatory filing that turned out to be false. But they also said couching a statement as an opinion is no magic bullet for securities defendants.
Less than a month after losing a bid to derail antitrust allegations by Capital One, Intellectual Ventures failed to persuade a different judge to shelve Toshiba's claims that IV improperly uses its vast patent portfolio to wield monopoly power.
Four years after holding that federal law trumps California's ability to block class action waivers, the U.S. Supreme Court plunged back into the consumer arbitration debate on Monday in a case involving the satellite television provider DirecTV Inc.
Lieff Cabraser and another outside law firm stand to earn $43 million from Ohio's portion of a $714 million settlement with The Bank of New York Mellon. But even though Ohio's attorney general signed off on the contingency deal, he's backing a bill that would have made it impossible.
The thriller-worthy case of Paul Ceglia took a bizarre turn when Ceglia, facing criminal charges for allegedly defrauding Facebook, vanished with his family. But if you believe Ceglia's lawyers, that's no reason to close the case that landed Ceglia in trouble in the first place.
Dennis Kelleher, the former Skadden partner-turned Wall Street watchdog, hit a litigation dead end this week in his crusade for financial reform.
Facing litigation over California's toxic chemical law, Prop 65? Better call Corash.
Despite the efforts of former U.S. Solicitor General Paul Clement, the International Franchise Association fell short this week in its bid to scuttle part of Seattle's landmark $15-per-hour minimum wage law.
Irving Picard has hit a wall in his efforts to claw back nearly $2 billion in "fictitious" profits pocketed by Bernie Madoff's customers. Can Goldstein & Russell's Thomas Goldstein succeed where Picard's partners at Baker & Hostetler have failed?
In a quartet of lawsuits filed last year, plaintiff Priceplay.com accused AOL, Facebook, Google and LinkedIn of infringing two patents related to online price auctions. But after a victory this week for AOL's lawyers at Covington & Burling, it looks like all four suits could soon be history.
Novartis AG is turning into a serial litigation target for plaintiffs lawyers at Sanford Heisler Kimpel, a firm that's already secured more than $270 million in settlements related to the pharmaceutical company's employment practices.
HBO's film about accused killer Robert Durst may be dominating the headlines, but it's a mostly forgotten HBO segment on Indian child labor that's scheduled to put the broadcaster and its lawyers at Williams & Connolly in front of a Manhattan federal jury next month.
The firm helped shield Avon Products Inc. from more fallout over allegations that the cosmetics company bribed officials in a half-dozen foreign countries, convincing a judge in Manhattan to toss shareholder derivative claims related to the long-simmering bribery flap.
Both final episodes of the world's wackiest legal dramedy open April 20. Will Donziger jump the shark?
BlackBerry Ltd. may still be grasping at the heels of its smartphone competitors, but the company's lawyers aren't having much trouble beating back investor class actions over its spotty performance.
Lawyers at Hausfeld LLP and Scott & Scott announced the $135 million settlement on Friday. Ten other major banks remain in the plaintiffs' sights for allegedly manipulating the $5 trillion-a-day forex market.
Now that GlaxoSmithKline has abandoned an antitrust claim at the heart of its licensing battle with Abbott Labs over the drug Norvir, Abbott's lawyers at Kirkland & Ellis are looking to put the rest of the case to bed before a scheduled trial.
Plenty of people weren't happy with this week's $7.4 million copyright infringement verdict over Robin Thicke and Pharrell Williams' "Blurred Lines." Busch, who represents the heirs of Marvin Gaye who won the award, says the critics just don't get it.
After four years of courtroom wrangling and more than $20 billion in settlements, the first trial is set to begin Monday in the Federal Housing Finance Agency's litigation campaign against banks that packaged and sold mortgage-backed securities.
The settlement looks at first glance like the largest since unpaid interns began suing their former companies for back wages roughly three years ago. Then we read the fine print.
The Second Circuit on Wednesday lowered the chances that "zombie" whistleblowers who offered their tips to the SEC before Dodd-Frank will ever see a reward.
After almost five years of intense and closely-watched litigation, defense lawyers at Sullivan & Cromwell and Paul Hastings may finally be close to knocking out a proposed gender discrimination class action against Goldman Sachs & Co.
Facebook may hope that Paul Ceglia's sudden disappearance will support the notion that he's always been a con artist, and that DLA Piper and Milberg must have known that when they backed his ownership claims against the social networking giant.
A Delaware judge threw out fraud allegations that Perelman's Harland Clarke Holdings had leveled against Michael Milken and GroupOn executive Raman Srinivasan.
PNC Bank said it would appeal Monday's verdict after defense lawyers at Williams & Connolly failed to dislodge claims stemming from an alleged fraud scheme involving prepaid funeral services.
With 40 million customers and $4 billion in annual sales, Johnson & Johnson and other major contact lens manufacturers are looking to some like a class action litigation bonanza.
A judge in Manhattan tossed claims that the Keith Haring Foundation destroyed the value of more than 100 purported Haring works by publicly calling them fakes.
With 80 appearances under his belt, Sidley Austin's Carter Phillips claims to hold the title for most U.S. Supreme Court arguments by a private lawyer. But he won't have a chance to argue for Gilead Sciences in a patent fight with Indian drug maker Natco Pharma.
Lawyers at Susman Godfrey initially sought $300 million over claims that Symantec infringed two IV patents. Now the judge says he may slash their $17 million verdict even further—or toss it altogether if Symantec's lawyers at Latham & Watkins can show that the patents shouldn't have been issued in the first place.
Mitt Romney's 2012 presidential campaign may have ended in defeat, but the campaign's lawyers at Jones Day succeeded in fending off a former Illinois state employee's attempts to tie Romney for President Inc. to alleged racketeering.
With just 30 lawyers and no website, Beus Gilbert keeps punching above its weight.
Less than two weeks after a New York jury socked the Palestinian Authority and the PLO with a $655.5 million verdict for supporting deadly terrorist attacks in Israel, a second judge in Washington, D.C., has thrown out parallel Anti-Terrorism Act claims on jurisdictional grounds.
Lawyers for Goldman Sachs, JPMorgan Chase, the London Metal Exchange and other defendants drove another stake through claims that the companies conspired to stockpile aluminum in warehouses and drive up prices.
Handing a win to Kellogg Huber's David Frederick, the Tenth Circuit reinstated the National Credit Union Administration's lawsuit against Barclays PLC over allegedly shoddy mortgage-backed securities.
Thought major investor class action litigation sparked by the Bernie Madoff affair was over? Think again.
The U.S. Patent and Trademark Office dealt a blow this week to the Chicago Board Options Exchange, invalidating three patents that the CBOE had asserted in an infringement lawsuit against International Securities Exchange.